BAC
About:
BAC BV provides affinity purification products and services for the biopharmaceutical market.
Website: http://www.bacbv.com
Top Investors: Unilever Ventures, FF&P Private Equity
Description:
BAC BV provides affinity purification products and services for the biopharmaceutical market. Their CaptureSelect products are used for drug discovery upto manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids.
Total Funding Amount:
1.5M EUR
Headquarters Location:
Waltham, Massachusetts, United States
Founded Date:
1995-01-01
Founders:
Number of Employees:
10001+
Last Funding Date:
2008-09-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai